drugset / Trial / NCT00861185
Study to Assess Safety and Efficacy of Oral Senicapoc Administration on Exercise-induced Asthma
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine whether 4 weeks of dosing with senicapoc alleviates exercise induced asthma symptoms.
Timeline
- Start
- 2009-03
- Primary completion
- 2009-07
- Completion
- 2009-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Senicapoc | Small molecule | 40 mg | Oral |